Clinical Trial Update: Catatonia in Nodding Syndrome and Lorazepam Treatment [Phase 1]

View source ↗

Summary

Phase 1 study evaluating lorazepam for catatonia in nodding syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catatonia
• Nodding Syndrome

Drugs mentioned

• Lorazepam (Lorazepam)

Snippet

Sponsor: Makerere University | Conditions: Catatonia, Nodding Syndrome | Phase 1 | Status: COMPLETED